Newsletter

AMW GmbH, a pharmaceutical company specialising in biodegradable implants, has initiated a research and development project aimed at increasing the efficiency of formulation development through the use of AI. The project is being scientifically supported by the research group of Prof. Dr. Olivia Merkel (LMU Munich), an expert in the field of drug delivery. The […]

A study conducted at the University of Helsinki and Helsinki University Hospital has evaluated the performance of the MESI mTABLET TBI toe pressure photoplethysmography device against a stationary laser Doppler flow meter, the current gold standard for assessing superficial microvessels. The University of Helsinki study shows that the MESI mTABLET TBI demonstrates high concordance with […]

We are delighted that the new product RoTecPSMA® from our portfolio company ROTOP has received marketing authorisation in the UK. RoTecPSMA® is a diagnostic kit that uses technetium-99m and has been specially developed for SPECT imaging in prostate cancer patients. It is the first PSMA SPECT tracer to be approved in a European country. It […]

At its 181st meeting in March 2025, the European Pharmacopoeia Commission (EPC) adopted a new general chapter entitled ” High-throughput sequencing for the detection of viral extraneous agents (2.6.41)”. The new chapter will be published in edition 12.2 of the European Pharmacopoeia (Ph. Eur.) in October 2025 and will enter into force on 1 April […]

SHS Capital recently hosted another Portfolio Workshop, bringing together executives from SHS portfolio companies to discuss how to promote effective leadership, scale businesses efficiently and manage growth in dynamic markets. Under the expert moderation of Thalia Ucksche, Bernhard Stieger and Alexander Liolios from Spencer Stuart, the workshop focused on the changing requirements of scaling companies […]

The annual SHS Investors’ Day took place again this year in Tübingen. Investors, portfolio representatives, senior advisors, healthcare experts and other valued guests were warmly welcomed at the Hotel Krone in the heart of Tübingen. The day offered engaging presentations on healthcare topics and an outlook on economic development and medical innovations over the coming […]

InnoRa GmbH contributes over 20 years of experience in the development of innovative cardiovascular devices and their translation into clinical trials to the partnership. The partnership also includes an undisclosed investment by InnoRa. Professor Bruno Scheller, a renowned expert in interventional cardiology and co-founder of InnoRa will join the Supervisory Board of CoreMedic.Josef Bogenschütz, CEO […]

Maya combines robotic, sensor-based and MTT (Medical Training Therapy) devices on a seamless platform that optimises therapy for upper and lower extremities. By connecting all Tyromotion devices, Maya provides a complete overview of the patient’s progress, making therapy more efficient and coordinated.In rehabilitation, it is crucial to focus on the patient’s individual goals. With Maya, […]

The Galician Health Service (SERGAS) has invested EUR 5 million in MESI mTABLET diagnostic systems, equipping care teams with devices that enable them to measure vital signs, such as ECG and blood pressure, directly in patients’ homes. This initiative has already enabled more than 17,500 home visits in 2024 and significantly improved access to high-quality […]

In partnership with medtech company Abbott, Simulands, a global leader in medical simulation technology and innovative training solutions, announces the opening of this groundbreaking facility. This state-of-the-art centre in Eschborn, Germany, sets new standards in medical education by placing physicians, students and their learning experience at the forefront of its concept. The centre represents a […]

Meet our SHS Capital colleagues Sascha Alilovic, Dr. Cornelius Maas and Georg Helg at the MEDICA from 11 to 14 November in Düsseldorf. MEDICA is one of the largest medical B2B trade fairs in the world. For over 40 years, it has been a fixed date in the calendar of all experts. Please feel free […]

Since SHS became a member of the UN PRI and even before that, we have endeavoured to comply with ESG guidelines both within our own company and at all our portfolio companies. Existing portfolio companies are regularly subjected to an ESG review. A dedicated ESG review is also carried out for potential new portfolio companies […]